Differentiation and Cancer Group, Institute for Research and Innovation in Health (i3S), Institute of Molecular Pathology and Immunology, University of Porto (IPATIMUP), 4200-135 Porto, Portugal.
TOXRUN-Toxicology Research Unit, University Institute of Health Sciences, CESPU, CRL, 4585-116 Gandra, Portugal.
Int J Mol Sci. 2022 Sep 14;23(18):10692. doi: 10.3390/ijms231810692.
Ovarian cancer (OC) has a specific type of metastasis, via transcoelomic, and most of the patients are diagnosed at advanced stages with multiple tumors spread within the peritoneal cavity. The role of Malignant Ascites (MA) is to serve as a transporter of tumor cells from the primary location to the peritoneal wall or to the surface of the peritoneal organs. MA comprise cellular components with tumor and non-tumor cells and acellular components, creating a unique microenvironment capable of modifying the tumor behavior. These microenvironment factors influence tumor cell proliferation, progression, chemoresistance, and immune evasion, suggesting that MA play an active role in OC progression. Tumor cells induce a complex immune suppression that neutralizes antitumor immunity, leading to disease progression and treatment failure, provoking a tumor-promoting environment. In this review, we will focus on the High-Grade Serous Carcinoma (HGSC) microenvironment with special attention to the tumor microenvironment immunology.
卵巢癌 (OC) 具有特定类型的转移途径,即经体腔转移,大多数患者在晚期被诊断出,且腹腔内有多个肿瘤扩散。恶性腹水 (MA) 的作用是充当肿瘤细胞从原发部位到腹膜壁或腹膜器官表面的运输者。MA 包含细胞成分(包括肿瘤细胞和非肿瘤细胞)和无细胞成分,形成一个独特的微环境,能够改变肿瘤的行为。这些微环境因素影响肿瘤细胞的增殖、进展、化疗耐药性和免疫逃逸,表明 MA 在 OC 进展中发挥积极作用。肿瘤细胞诱导复杂的免疫抑制,从而中和抗肿瘤免疫,导致疾病进展和治疗失败,引发肿瘤促进环境。在这篇综述中,我们将重点关注高级别浆液性癌 (HGSC) 的微环境,特别关注肿瘤微环境免疫学。